@grainland1
actief 1 dag, 5 uren geleden
Treatment with Omnitrope
was discontinued following diagnosis of malignancy in 16 patients. The tumors occurred after a mean of 79.4 months of recombinant hormone GH (rhGH) treatment overall.
Based on this snapshot of data from PATRO Adults, Omnitrope
treatment is tolerated in adult patients with GH deficiency in a real-life c […] Bekijken